This site is intended for healthcare professionals
Psoraisis Learning Zone

Featured Educational Video

Read time: 2 mins

ECLIPSE study comparison of IL-17 and IL-23

Professor Blauvelt describes the recent important head-to-head studies in psoriasis, including the ECLIPSE study which compared an IL-17 and and IL-23 inhibitor over 52 weeks.

Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

This content has been developed independently by Medthority who previously received educational funding in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.